Outcomes following natalizumab exposure throughout pregnancy in patients with relapsing multiple sclerosis (RMS) or Crohn's disease

Authors
Category Primary study
JournalNeurology
Year 2017
This article has no abstract
Epistemonikos ID: 2558f755793eb03871c16486db69c670d3e86403
First added on: Feb 08, 2025